Clinical progressive supranuclear palsy: differential diagnosis by IBZM-SPECT and MRI

Progressive Supranuclear Palsy

John C. Steele · Archives of Neurology · 1964 · 1.9K citations

Life Sciences, Neurology, Neuroscience +13

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

Thomas Brücke, I. Podreka, P. Angelberger et al. · Journal of Cerebral Blood Flow & Metabolism · 1991 · 207 citations · Full text

Medicine, Neuroscience, Pharmacology +17

In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.

Hank F. Kung, Sangren Pan, Mei‐Ping Kung et al. · PubMed · 1989 · 164 citations

Medicine, Neuroscience, Pharmacology +15

In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.

Hank F. Kung, Abass Alavi, Wei Hung Chang et al. · PubMed · 1990 · 141 citations

Medicine, Nuclear Medicine, Pharmacology +14

¹²³ I‐iodobenzamide‐SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism

Johannes Schwarz, Klaus Tatsch, G. Arnold et al. · Neurology · 1992 · 137 citations

Medicine, Neurology, Pharmacology +17